These Cholesterol-Reducers May Save Lives. So Why Aren’t Heart Patients Getting Them? by GINA KOLATA

This entry was posted in Health Weight Watchers and tagged Health NYT on by

Powerful PCSK9 inhibitors were supposed to revolutionize care for cardiac patients. But insurers and other payers balked at sky-high prices.

Published: October 2, 2018 at 02:00AM

from NYT Health https://ift.tt/2DOZiTD